Antos, J
Early on, the shifts tend to be modest: a quieter inflammatory tone, slightly less morning stiffness, better tolerance of activities that used to aggravate the issue
Disclosures: Janet Chu: Gilead Sciences, Inc.: Grant/Research Support, Nghiem Ha: Nothing to Disclose, Mandana Khalili: gilead sciences: Grant/Research Support, GSK pharmaceuticals: Consultant, Intercept pharmaceuticals: Grant/Research Support, Gilead Sciences Inc: Consultant, Max Goldman: Eli Lilly: Stock - publicly traded company, Novo Nordisk: Stock - publicly traded company, Eli Lilly: Stock - publicly traded company, Madrigal: Stock - publicly traded company, Bilal Hameed: Gilead: Grant/Research Support, Intercept: Grant/Research Support, Pliant: Grant/Research Support, Novo Nordisk: Grant/Research Support, Madrigal: Grant/Research Support, Salix: Grant/Research Support, Mallinckrodt: Advisor, Pleiogenix: Advisor, CLDF: Advisor, Gilead: Consultant, Pioneering Medicine VII Inc: Consultant, Surrozen: Consultant, Pleiogenix: Stock privately held company, Scholars In Medicine: Speaking and Teaching, Rena Fox: Nothing to Disclose 1152 DIFFERENTIAL PROGNOSIS AND IMPACTS OF CARDIOMETABOLIC RISK FACTORS AND ALCOHOL INTAKE IN MASLD AND METALD PATIENTS Young Chang JAE YOUNG JANG 1 Soung Won Jeong 1 , 1 Soonchunhyang University Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) and MASLD with increased alcohol intake (MetALD) are distinct yet overlapping conditions that significantly impact liver disease progression and mortality
If you've ever found that your joint pain is reduced after consuming gelatin-based gummies (which are almost pure collagen), you'll understand why bone broth is so effective
Metabolomics in Clinical Practice: Improving Diagnosis and Informing Management
